AMG National Trust Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AMG National Trust Bank's BMY Position: Q2 2026 in Review
AMG National Trust Bank reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, selling an estimated $156K and leaving 14,664 shares worth $845K. The position accounts for 0.02% of the portfolio, ranked #283.
AMG National Trust Bank first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.35M in Q1 2025. 2,531 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- AMG National Trust Bank held 14,664 shares of Bristol-Myers Squibb worth $845K as of Q2 2026.
- AMG National Trust Bank sold 2,711 Bristol-Myers Squibb shares in Q2 2026, an estimated $156K.
- Bristol-Myers Squibb made up 0.02% of AMG National Trust Bank's portfolio in Q2 2026, its #283 holding.
- AMG National Trust Bank first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
- AMG National Trust Bank's Bristol-Myers Squibb position peaked at $7.35M in Q1 2025.
- 2,531 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.